Volume 11, Number 7—July 2005
Perspective
Drug-resistant Neisseria gonorrhoeae in Michigan
Table 4
Prevalence of ciprofloxacin-resistant gonorrhea infection among surveillance population
| % patients with QRNG (n/total) | Prevalence ratio (95% confidence interval) | p value | |
|---|---|---|---|
| Sex | 1.02 (1.00–1.04) | 0.03 | |
| Male | 3 (19/697) | ||
| Female | 1 (3/375) | ||
| Men who have sex with men | 1.14 (1.05–1.24) | <0.0001 | |
| Yes | 14 (12/87) | ||
| No | 1 (7/488) | ||
| White | 1.07 (1.02–1.11) | <0.0001 | |
| Yes | 7 (13/178) | ||
| No | 1 (9/896) | ||
| Discharge and/or dysuria | 0.991 (0.960–1.02) | 0.57 | |
| Yes | 2 (16/724) | ||
| No | 3 (4/131) | ||
| History of gonorrhea | 0.991 (0.967–1.02) | 0.52 | |
| Yes | 2 (7/285) | ||
| No | 3 (14/425) | ||
| >40 y of age | 1.02 (0.975–1.06) | 0.30 | |
| Yes | 4 (3/84) | ||
| No | 2 (19/990) |
Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.